Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy

One of the main challenges for immune checkpoint blockade antibodies lies in malignancies with limited T-cell responses or immunologically “cold” tumors. Inspired by the capability of fever-like heat in inducing an immune-favorable tumor microenvironment, mild photothermal therapy (PTT) is proposed...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Liping, Li, Yanan, Du, Yunai, Zhang, Yiyi, Wang, Xiuxia, Ding, Yuan, Yang, Xiangliang, Meng, Fanling, Tu, Jiasheng, Luo, Liang, Sun, Chunmeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814770/
https://www.ncbi.nlm.nih.gov/pubmed/31653838
http://dx.doi.org/10.1038/s41467-019-12771-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814770/
https://www.ncbi.nlm.nih.gov/pubmed/31653838
http://dx.doi.org/10.1038/s41467-019-12771-9

Ejemplares similares